Consents and 42 CFR Part 2 - New Rules for Re-Release of Substance Use Disorder Information

Managing release health information when it may involve substance use disorder treatment information requires good knowhow. This course focuses on the issues involved in doing so and how to handle it. It explains how HIPAA relates to information management and release and what processes are required for various releases of information under the HIPAA rules, including release according to individual access requests, and under consents and HIPAA authorizations.

Live Online Training
June 11, Tuesday 10:00 AM PDT | 01:00 PM EDT (90 Min)

$229.00
One Dial-in One Attendee
$599.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

Recorded Version

$299.00
1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section 48 hrs after completion of Live training

Training CD / USB Drive

$399.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days after completion of Live training
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

When substance use disorder treatment information is involved, you need to know how to distinguish it from the “regular” health information, to be able to cover the relevant extra protections. If it is rarely dealt with in your organization, you may be able to use the functions in your EHR to flag the information. And the substance information you take may or may not be under SAMHSA based on whether you have a department or not, or even a response team that specializes in SAMHSA-related situations. It is important for you to understand your status under the rules prior to releasing information inappropriately. What qualifies treatment that falls under SAMHSA will be discussed in this webinar.

If your organization offers services that create information that is under the SAMHSA regulations, you will need to set up the consent and release of information processes that are required to be followed for information releases under 42 CFR Part 2. This involves getting the proper consents upon establishment of the relationship, as well as managing consents for releases that may be necessary after the initial establishment of the relationship. The session will include an explanation of the consent and release requirements that have to be followed.

When you release information under HIPAA, there are no special notices required to be placed on the records. But when you release information under SAMHSA, each document must have a notice that details that re-disclosure is not permitted without a new consent. Complicating matters are updated rules that allow a consent that permits a re-release to a defined team of providers caring for the individual, but then require meticulous documentation of to whom the information has been released under such a consent. The session will go over the rules on consents and re-release of information. Mishandling such consents can result in significant penalties.

Areas Covered in the Webinar:
  • What HIPAA allows, what SAMHSA requires, and the differences will be explained.
  • How to determine if the services you provide place you under FERPA or 42 CFR Part 2.
  • Exploring the means for making sure substance abuse treatment information receives the appropriate protections.
  • The consent and release requirements under HIPAA and 42 CFR Part 2 will be explained.
  • Re-release of information released under 42 CFR Part 2 under the new rules will be discussed.
  • Requirements for providing an accounting of disclosures of Part 2 information will be explained.
  • Sharing of information with family and friends in an overdose incident will be explored.
Who Will Benefit:

This webinar will provide valuable assistance to all personnel in:

Social Service Agencies, Medical offices, practice groups, hospitals, academic medical centers, insurers, business associates (shredding, data storage, systems vendors, billing services, etc). The titles are

  • Compliance director
  • CEO
  • CFO
  • Privacy Officer
  • Security Officer
  • Information Systems Manager
  • HIPAA Officer
  • Chief Information Officer
  • Health Information Manager
  • Healthcare Counsel/lawyer
  • Office Manager
  • Contracts Manager
Instructor Profile:
Jim Sheldon-Dean Jim Sheldon-Dean

Principal and Director of Compliance Services, Lewis Creek Systems, LLC

Jim Sheldon-Dean is the founder and director of compliance services at Lewis Creek Systems, LLC, a Vermont-based consulting firm founded in 1982, providing information privacy and security regulatory compliance services to a wide variety of health care entities. He is a frequent speaker regarding HIPAA, including speaking engagements at numerous regional and national healthcare association conferences and conventions and the annual NIST/OCR HIPAA Security Conference. Sheldon-Dean has more than 19 years of experience specializing in HIPAA compliance, more than 37 years of experience in policy analysis and implementation, business process analysis, information systems and software development, and eight years of experience doing hands-on medical work as a Vermont certified volunteer emergency medical technician. Sheldon-Dean received his B.S. degree, summa cum laude, from the University of Vermont and his master’s degree from the Massachusetts Institute of Technology.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed